Rayence Co. Ltd Total Liabilities

Latest as of June 2026: ₩29.87 Billion KRW ≈ $20.24 Million USD

Rayence Co. Ltd total liabilities. Based on the latest financial reports, Rayence Co. Ltd (228850) has total liabilities worth ₩29.87 Billion KRW (≈ $20.24 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 228850 financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Rayence Co. Ltd (2015–2025)

Total liabilities of Rayence Co. Ltd from 2015 to 2025. This chart illustrates how Rayence Co. Ltd's total liabilities have evolved over time, based on quarterly financial data.

Rayence Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Rayence Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Electrotherm (India) Limited NSE:ELECTHERM	India	Rs21.28 Billion
Orthex Oyj HE:ORTHEX	Finland	€47.28 Million
Dual Co Ltd KO:016740	Korea	₩289.01 Billion
MHC Plantations Bhd KLSE:5026	Malaysia	RM435.98 Million
NAU IB Capital KQ:293580	Korea	₩66.47 Billion
Resource Alam Indonesia Tbk JK:KKGI	Indonesia	Rp33.58 Million
Artiva Biotherapeutics, Inc. Common Stock NASDAQ:ARTV	USA	$19.64 Million
SHEPHERD NEAME P. CONS. F:43Y	Germany	€183.58 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Rayence Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Rayence Co. Ltd.

Liquidity & Leverage Metrics

Rayence Co. Ltd Total Liabilities Ratios Explained

Rayence Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	11.99	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Rayence Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Rayence Co. Ltd (2015–2025)

The table below shows the annual total liabilities of Rayence Co. Ltd from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩23.85 Billion ≈ $16.16 Million	-2.84%
2024-12-31	₩24.55 Billion ≈ $16.64 Million	-33.09%
2023-12-31	₩36.69 Billion ≈ $24.86 Million	-1.51%
2022-12-31	₩37.25 Billion ≈ $25.24 Million	-9.63%
2021-12-31	₩41.22 Billion ≈ $27.94 Million	+12.78%
2020-12-31	₩36.55 Billion ≈ $24.77 Million	-3.24%
2019-12-31	₩37.78 Billion ≈ $25.60 Million	+96.06%
2018-12-31	₩19.27 Billion ≈ $13.06 Million	-2.74%
2017-12-31	₩19.81 Billion ≈ $13.42 Million	-20.56%
2016-12-31	₩24.94 Billion ≈ $16.90 Million	-26.79%
2015-12-31	₩34.06 Billion ≈ $23.08 Million	--

About Rayence Co. Ltd

KQ:228850 Korea Medical Devices

Market Cap

$82.86 Million

₩122.27 Billion KRW

Market Cap Rank

#19742 Global

#1018 in Korea

Share Price

₩7770.00

Change (1 day)

+1.04%

52-Week Range

₩4895.00 - ₩8610.00

All Time High

₩20930.72